AbbVie/Roche drug gets U.S. approval for a rare type of leukemia
April 11, 2016 at 12:43 PM EDT
WASHINGTON, April 11 (Reuters) - AbbVie Inc won U.S. regulatory approval on Monday for a new drug to treat patients with a rare type of chronic lymphocytic leukemia, a blood cancer.
